• Info
  • Insider Ownership

Insider Trading & Ownership of Gwen A. Melincoff

Location
Carmiel
Summary
The estimated net worth of Gwen A. Melincoff is at least $1,706,965 dollars as of 04 Sep 2025. Gwen A. Melincoff is the Director of COLLEGIUM PHARMACEUTICAL, INC and owns shares of COLLEGIUM PHARMACEUTICAL, INC (COLL) stock worth about $1.69M. Gwen A. Melincoff is the Director of Protalix BioTherapeutics, Inc. and owns shares of Protalix BioTherapeutics, Inc. (PLX) stock worth about $12.1K.
Signature
/s/ Joseph R. Magnas, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Gwen A. Melincoff files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Gwen A. Melincoff

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
COLL COLLEGIUM PHARMACEUTICAL, INC Director $1,694,890 16 May 2024
PLX Protalix BioTherapeutics, Inc. Director $12,075 03 Sep 2025
GANX Gain Therapeutics, Inc. Director 24 Jun 2025
SLNO SOLENO THERAPEUTICS INC Director 25 May 2023

Insider Transactions Reported by Gwen A. Melincoff:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.